192 related articles for article (PubMed ID: 12833662)
1. Prioritizing the human genome: knowledge management for drug discovery.
Golden JB
Curr Opin Drug Discov Devel; 2003 May; 6(3):310-6. PubMed ID: 12833662
[TBL] [Abstract][Full Text] [Related]
2. The journal of pharmacy and pharmacology 2008.
Jones DS
J Pharm Pharmacol; 2009 Jan; 61(1):1-2. PubMed ID: 19126290
[No Abstract] [Full Text] [Related]
3. When drugs development meets genomics.
Leung YF; Lam DS; Pang CP
Pharmacogenomics J; 2001; 1(4):237-8. PubMed ID: 11908765
[No Abstract] [Full Text] [Related]
4. The impact of systems approaches on biological problems in drug discovery.
Hood L; Perlmutter RM
Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
[No Abstract] [Full Text] [Related]
5. Applying advanced delivery technologies to enable and improve drug development. 8-9 December 2004, London, UK.
Uchegbu IF
IDrugs; 2005 Feb; 8(2):112-4. PubMed ID: 15696410
[No Abstract] [Full Text] [Related]
6. Can cell systems biology rescue drug discovery?
Butcher EC
Nat Rev Drug Discov; 2005 Jun; 4(6):461-7. PubMed ID: 15915152
[TBL] [Abstract][Full Text] [Related]
7. Drug Discovery Technology 2003--seventh annual conference and exhibition. Science, business and IT for drug discovery II. 31 March-3 April 2003, Stuttgart, Germany.
Mackonochie M
IDrugs; 2003 May; 6(5):420-2. PubMed ID: 12841200
[No Abstract] [Full Text] [Related]
8. Recent advances in the discovery and delivery of vaccine adjuvants.
O'Hagan DT; Valiante NM
Nat Rev Drug Discov; 2003 Sep; 2(9):727-35. PubMed ID: 12951579
[TBL] [Abstract][Full Text] [Related]
9. Beyond the genome--SMi Conference 27-28 January 2003, London, UK.
Swinton J; Sheridan JM; Henning SW
IDrugs; 2003 Mar; 6(3):203-6. PubMed ID: 12838986
[TBL] [Abstract][Full Text] [Related]
10. Perspective from the founding editors. Preface.
Juliano R; Poste G; Tomlinson E
Adv Drug Deliv Rev; 2013 Jan; 65(1):3-4. PubMed ID: 22940253
[No Abstract] [Full Text] [Related]
11. Drug Delivery Systems--9th US-Japan symposium.
Uhland S
IDrugs; 2008 Mar; 11(3):186-8. PubMed ID: 18311655
[No Abstract] [Full Text] [Related]
12. Pharmaceutical prospects for RNA interference.
Schiffelers RM; Woodle MC; Scaria P
Pharm Res; 2004 Jan; 21(1):1-7. PubMed ID: 14984251
[TBL] [Abstract][Full Text] [Related]
13. Anti-infectives in the 21st century.
Clough J
Drug Discov Today; 2002 Oct; 7(20):1036-8. PubMed ID: 12546891
[No Abstract] [Full Text] [Related]
14. Drug Delivery 2007--New technologies, partnering and strategies for the future.
Stevenson L
IDrugs; 2007 Jun; 10(6):388-90. PubMed ID: 17642001
[No Abstract] [Full Text] [Related]
15. Value of novelty?
Ma P; Zemmel R
Nat Rev Drug Discov; 2002 Aug; 1(8):571-2. PubMed ID: 12402497
[No Abstract] [Full Text] [Related]
16. Exploiting novel cell cycle targets in the development of anticancer agents.
Wong CF; Guminski A; Saunders NA; Burgess AJ
Curr Cancer Drug Targets; 2005 Mar; 5(2):85-102. PubMed ID: 15810874
[TBL] [Abstract][Full Text] [Related]
17. Future DDS by qualified science of science for hybrid, hi-quality and husbandry.
Nagai T
J Drug Target; 2006; 14(7):446-7. PubMed ID: 17062390
[No Abstract] [Full Text] [Related]
18. Molecular targets and cancer therapeutics.
Westwell AD
Drug Discov Today; 2004 Dec; 9(24):1042-4. PubMed ID: 15582792
[No Abstract] [Full Text] [Related]
19. Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.
Sawyer TK
Chem Biol Drug Des; 2006 Mar; 67(3):196-200. PubMed ID: 16611212
[No Abstract] [Full Text] [Related]
20. Fluorescence imaging: applications in drug delivery research.
Agarwal A; Tripathi PK; Tripathi S; Jain NK
Curr Drug Targets; 2008 Oct; 9(10):895-8. PubMed ID: 18855624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
